Risk of hepatic events associated with use of sodium-glucose cotransporter-2 inhibitors versus glucagon-like peptide-1 receptor agonists, and thiazolidinediones among patients with metabolic dysfunction-associated steatotic liver disease
FDA approves first generic of once-daily GLP-1 injection to lower blood sugar in patients with type 2 diabetes [Internet]
The most common sleep-related effects include mild insomnia during dose escalation (affecting roughly 8% of users) and occasional vivid dreams, both of which typically resolve within 4 to 6 weeks
Notably, a poll indicates that 37% of individuals with chronic health issues need financial support, yet only 41% receive it, highlighting the importance of utilizing these options
However, it may be helpful to those seeking a more gradual approach to weight loss while potentially providing overall health benefits like anti-inflammatory and neuroprotective effects
It lowers FGF21, a hormone associated with metabolic stress, which might indicate reduced strain on the liver